Phase
Condition
Hiv
Treatment
N/AClinical Study ID
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
Adult (18 years-old or older)
Eligibility to undergo apheresis procedures; or, for participants who areunable to undergo apheresis, willingness to undergo blood draw for researchpurposes that remain within safety guidelines established by NIH policy.
Willingness to give informed consent for the storage of blood or tissue samplesand HLA testing
AND at least one of the following:
An HIV-seropositive participant categorized as an LTNP as defined by clinical andlaboratory criteria, regardless of HLA class I type.
HIV-seropositive progressors
Persons who are seronegative for HIV but are family members of seropositiveparticipants exhibiting immunologic control of HIV
Exclusion
EXCLUSION CRITERIA:
Pregnant
Cardiovascular instability, severe anemia, inadequate venous access, severecoagulation disorder, or any other condition that the Principal Investigator orApheresis Unit staff considers a contraindication to the apheresis procedure orresearch blood draw.
Any condition that, in the opinion of the investigator, contraindicatesparticipation in this study.
Study Design
Study Description
Connect with a study center
National Institutes of Health Clinical Center
Bethesda, Maryland 20892
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.